Sagittarius Life Science Corp (TPEX:3205)
52.30
+1.10 (2.15%)
Oct 31, 2025, 1:30 PM CST
Sagittarius Life Science Revenue
Sagittarius Life Science had revenue of 112.69M TWD in the quarter ending June 30, 2025, a decrease of -4.75%. This brings the company's revenue in the last twelve months to 446.03M, down -0.14% year-over-year. In the year 2024, Sagittarius Life Science had annual revenue of 467.75M with 6.20% growth.
Revenue (ttm)
446.03M
Revenue Growth
-0.14%
P/S Ratio
7.92
Revenue / Employee
3.98M
Employees
112
Market Cap
3.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 467.75M | 27.29M | 6.20% |
| Dec 31, 2023 | 440.46M | -88.61M | -16.75% |
| Dec 31, 2022 | 529.07M | -58.55M | -9.96% |
| Dec 31, 2021 | 587.61M | 29.43M | 5.27% |
| Dec 31, 2020 | 558.19M | 119.47M | 27.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| PharmaEssentia | 12.63B |
| Pegavision | 6.90B |
| Center Laboratories | 1.60B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |
| Caliway Biopharmaceuticals | 44.83M |